ClinicalTrials.gg
Not yet recruitingNCT07943169Updated Nov 17, 2026

Wear, Clinical Performance and Computerized Occlusal Evaluation of Hybrid Versus Lithium Disilicates Ceramic CAD/CAM Overlays in Endodontically Treated Molars: A 24-Month Comparative Randomized Clinical Trial

An interventional study of Hybrid Ceramics CAD/CAM overlays and Lithium disilicate CAD/CAM overlays in Endodontically Treated Molar, sponsored by Cairo University. Not yet recruiting. Open to participants aged 20 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-17.

Sponsored by Cairo University · Not applicable, Interventional, and Treatment

Updated Nov 17, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
44
Allocation
Randomized
Ages
20 Years to 50 Years
Sex
All
01

Study summary

This randomized clinical trial aims to compare the clinical performance, wear behavior and relative occlusal force distribution of hybrid ceramic and lithium disilicate CAD/CAM overlays in endodontically treated molars over a 24-month follow up period using Modified USPHS criteria, Geomagic control software and digital occlusal analyzer respectively

02

Conditions studied

  • Endodontically Treated Molar

Keywords

  • Hybrid Ceramics,
  • Lithium Disilicate
  • CAD/CAM overlays
  • Wear
03

In context

Lead sponsor

Cairo University is the lead sponsor of 4,956 studies on the registry; 1,466 are open to participants now.

Of its 37 completed or terminated interventional studies of FDA-regulated products, 5 (14%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 50 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Inclusion criteria of patients: Healthy patients, compliant, having good oral hygiene, willing to commit to the follow up periods, patients without parafunctional habits
  • Inclusion criteria of teeth included: endodontically treated first or second molars, opposing teeth present, consistent root canal fillings, no apical lesion or mobility present, large access cavities with at least one missing wall

Exclusion criteria

Exclusion Criteria:

  • Exclusion criteria of patients: patients having systemic diseases, pregnant females, not willing to commit to the follow up periods, patients with poor oral hygiene, patients having parafunctional habits
  • Exclusion criteria of teeth: endodontically treated anterior or premolar teeth, endodontically treated third molars ,inconsistent root canal filling, presence of periapical lesion or mobility, lack of opposing teeth, conservative access cavities
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Participant, Outcomes assessor)
Enrollment
44 participants (estimated)

Study arms

  • Active comparator
    Endodontically treated molars will be restored using lithium disilicate CAD/CAM overlays

    Endodontically treated molars will receive lithium disilicate CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay.

    Other: Lithium disilicate CAD/CAM overlays

  • Experimental
    Experimental: Endodontically treated molars will be restored using Hybrid Ceramics CAD/CAM overlays

    Endodontically treated molars will receive Hybrid ceramics CAD/CAM overlays. Proper cavity preparation will be done based on the concepts of morphology driven preparation, followed by immediate dentin sealing, cavity optimization, scanning, milling and finally cementation of lithium disilicate overlay.

    Other: Hybrid Ceramics CAD/CAM overlays

Interventions

  • OtherHybrid Ceramics CAD/CAM overlays

    Endodontically treated molars will be prepared to receive hybrid ceramics overlays following the concept of morphology driven preparation. This includes cuspal reduction for the buccal and lingual walls, removal of all undermined enamel, slight flaring of the cavity walls to 6-10-degree divergence. After proper cavity preparation, immediate dentin sealing and cavity optimization will be done followed by scanning, milling and finally cementation of the overlay restoration.

  • OtherLithium disilicate CAD/CAM overlays

    Endodontically treated molars will be prepared to receive lithium disilicate CAD/CAM overlays. Preparation includes cuspal reduction of the buccal and lingual walls 1.5 to 2 mm, removal of all undermined enamel and slight flaring of the cavity walls to 6-10-degree divergence. Following cavity preparation, immediate dentin sealing and cavity optimization followed by scanning and milling of the restoration. Cementation will then follow based on manufacturer instructions using resin cement. Surface treatment including etching of the fitting surface using 9.5% hydrofluoric acid for 20 seconds followed by cleaning for 60 seconds using 37% phosphoric acid gel followed by silane application.

06

What researchers measure

Primary outcomes

  1. Wear Assessment

    The volumetric loss of the overlays will be measured by the software Geomagic Control Software

    Time frame: baseline, 12 and 24 months

Secondary outcomes

  1. Clinical performance (Marginal Adaptation)

    Marginal adaptation will be measured by two assessors following Modified USPHS criteria

    Time frame: baseline, 6, 12, 18 and 24 months

  2. Relative Occlusal load distribution

    relative occlusal load distribution will be measured by digital occlusal analysis system OccluSense

    Time frame: Immediately, 6 and 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No — The dataset contains coded but potentially re-identifiable clinical and patient information. Per the study confidentiality plan, data access is restricted to the principal investigator and study supervisors only with records stored securely under password-protected, limited access systems. No plan for sharing individual participant data with external researchers is currently in place.

No publications or documents are linked to this record.

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Dec 2026; primary completion for Dec 2027, 12 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Nov 11, 2026
First posted
Nov 17, 2026
StartEst.
Dec 15, 2026
Primary completionEst.
Dec 15, 2027
CompletionEst.
Dec 15, 2028
Last update
Nov 17, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 17, 2026
Show all 1 update
  1. Nov 17, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07943169
Lead sponsor
Cairo University
Responsible party
Farah Khaled El Hindawy (Assistant Lecturer, Conservative Dentistry Department, Cairo University) — Principal investigator
First posted
Nov 17, 2026
Start date
Dec 15, 2026 (estimated)
Primary completion
Dec 15, 2027 (estimated)
Completion
Dec 15, 2028 (estimated)
Last update
Nov 17, 2026

Study contacts

Farah Khaled El Hindawy, PhD candidate
Contact
farah-khaled@dentistry.cu.edu.eg
+201008771378
Aya Mohamed Adly, Lecturer
Contact
Aya.Mohamed@dentistry.cu.edu.eg
+201221528843

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Nov 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion